#cannabisaficionado

Cannabis

BC Bud Depot and the Collective Cannabis Consciousness

Matt Harvey from BC Bud Depot on genetics, Canada’s path to legalization, and why human connection is an integral part of the plant’s vitality.

Published

on

BC Bud Depot
Dense frosty trichomes cover the BC God Bud. PHOTOS | BC Bud Depot
Advertisement Back2Grow Advertisement

Based in British Columbia, Canada, award-winning seeds producer BC Bud Depot has been collecting elite cannabis strains for over 25 years. They have received over 21 Cannabis Cup awards, including seven first-place awards, nine top strain awards, six top three strain awards and an induction to the Seed Bank Hall of Fame in 2009.

Their genetics vault contains over two hundred unique strains, including the cultivar that put Canada on the map: the feminized version of the BC God Bud, whose dense and heavy crystal-coated nuggets make for an out-of-body experience.

Master grower Matt Harvey is the Founder and Chief Executive Officer of BC Bud Depot. We spoke exclusively to Harvey about genetics, Canada’s path to legalization, and why human connection is an integral part of the cannabis plant’s vitality.

Cannabis Aficionado: How did you get interested in breeding as opposed to growing flower?

Matt Harvey: Back in the late 1990s in BC, not many people were breeding in a serious way, or at least not with the intention of sharing their work outside of their tight-knit grow communities. Breeding in those days was mostly directed at increasing potency and yield, and shortening flowering times for an early harvest. Some really nice flower was hitting the market, but BC breeders were generally more interested in keeping their strains proprietary rather than distributing their genetics worldwide. The reputation and demand for BC-bred genetics was growing, so we stepped up to the plate and the rest became history in the making.

Growing top quality flower is part of the breeding process, and you can’t breed properly without also growing flower. How the flower is received by connoisseurs, in both taste and effects, is a key data set that informs our breeding processes. It’s also necessary to grow seedless flower to test peak cannabinoid production potential.

What makes a great seed better than a good seed?

For home gardeners and professionals alike, a great seed will pop a vigorous sprout, and a strong start to life is an important factor in achieving maximum growth potential, yield, and flavor. With a great seed, you know what to expect in the mature plant, since its genetics will be fully expressed and stable.

Every once in a while though, a great seed will grow a bit differently than what you’d expect and expresses a natural mutation that can open up a new trajectory into a breeding program, such as exhibiting ultra-high levels of a newly discovered cannabinoid or terpene. This recently happened with a Sweet God plant mutating to produce a staggeringly high CBG content.

Great seeds are always the most vigorous, and generally the most predictable, but occasionally the greatest seeds can be the most unpredictable of all.

BCBD’s The Big (G13 x Butterscotch Hawaiian) grows big in Israel.

How do you qualify genetics?

Genetics need to exhibit certain qualities in order to enter and to exit a breeding program. When elite cuts [clones] are used to start a breeding program, in cases where seeds are not available, it’s important to pollinate them with a well-known and stable male plant and to grow out a variety trial to see how stable the female genetics are.

There are so many poly-hybrids being grown these days — some of which produce amazing flower — but if their progeny is all over the map, it’s going to be harder to breed a stable strain; you’re more likely to achieve better results breeding with more stable parents. Sometimes it is absolutely worth it and sometimes it is not. It all depends on your goals and what you are setting out to achieve.

Cold storage tissue culture and genome sequencing are giving us new tools to pinpoint the qualifying factors that we breed for, and with more information and accurate data we can learn which genes express what, and apply this new knowledge to achieve our breeding goals.

Is there an interest in landrace strains?

Yes, and there always should be. I’m actually doing this interview from Colombia where there are some famous landrace strains, one of them being the Santa Marta Gold, which we are very excited to breed with.

Crossing a landrace with a known cultivar can produce amazing results. Since we’re discovering new cannabinoids all the time, and landraces can have exceptionally high levels of certain cannabinoids and terpenes, it’s important that we preserve them and their habitat. It’s like preserving the rainforest because it’s full of biological treasure that we haven’t even discovered yet. Too much inbreeding with cultivars can lead to an amalgamated gene pool, which is not very desirable.

Just like blue-blood families need to outbreed with barbarian genetics every so often to maintain their biological viability and vigor, so does cannabis. Mother Nature should always play a role in the breeding process, which we sometimes forget in our scientific age.

A cup full of the God.

What are the current strain trends that you are seeing?

We’re pleased to see that the kush craze seems to have passed. While there will always be a place for kush, it’s great to see things trending towards more interest in exotic fruit flavors, with more of an emphasis on terpene profile. Watermelon, cherry, peach, sours, and ice creams are all exotic terpene profiles with more rewarding qualities to breed for than just yield and THC potency. It is actually where the greater part of our interest has been since we started breeding. We are not surprised to see this trend, as cannabis connoisseurs worldwide develop more discerning palates.

While we still breed for cannabinoid ratios, and are inspired by all the new discoveries of the benefits of obscure cannabinoids like CBG, achieving these breeding goals relies more on lab data and strict variety trials, whereas the artistry of breeding is in teasing out new exotic terpene profiles; this is what makes our job fun.

Who is your favorite breeder/seed company other than yourself?

We are very impressed with the work of our homie Kasper at Kre8 Genetics, and are ecstatic to be working and collaborating with him after meeting at the San Bernardino Cup many years ago. Scott from Rare Dankness is also coming out with some great work these days. Of course, so much of our gratitude goes to all of the old school pioneers, breeders like our friend Soma, who have played such a key role in sending us on this journey.

What do you see as the most exciting thing happening in seed production and breeding?

We are all learning so much about the healing potential of cannabis these days. As we discover new cannabinoids and their medical applications, it’s very exciting to consider the positive potential that they can have for the world and our collective health.

It’s exciting to see new strains coming out with high levels of all these other little-known cannabinoids. When we see these random genetic mutations that yield astonishingly high levels of newly discovered cannabinoids, it confirms our long-held belief that cannabis has a collective consciousness that is in communication with us as people and wants to provide us with medicine.

Another great new development is high-tech genetic sequencing and cataloging, which promises to clarify our understanding of the cannabis gene pool, and provides us with useful data to inform our breeding programs.

The Black is a heavy hitting narcotic indica.

Are there any seeds you wish you had?

We’re always open to cataloging new seeds in our vault but at this point in time we have so much in the way of new genetics to work with, and with our breeding facilities at full capacity, we’re not in a place to be wishing for any new genetic stock.

I suppose, though, there’s always some unique old strains that would be great to work with, though unfortunately, we don’t expect to see them again. I’ll give a shout-out to the Legends Ultimate Indica circa 2002 — that would be a fun surprise.

Do you have a favorite cultivar to grow?

The BC God Bud will always be my personal favorite. Her pink pistils and fragrance are so familiar and dear to me. I’m sure a lot of veteran growers out there can relate to the way a favorite strain, cultivated lovingly for years upon years, becomes like an inseparable lifelong companion.

How many different seeds are in your inventory?

We offer over 120 elite strains bred by ourselves and other breeders. Our extensive vault of genetic breeding stock, collected over 25 years, houses thousands of different seeds in hundreds of different varieties.

Ladybugs protect the Black Goddess.

What’s something you are often asked that is a misconception about growing cannabis?

The largest, glaring misconception that I see in the cannabis world today is the assumption that high-quality flowers can be grown on an industrial scale, using industrial farming methods. I mean, it can be grown on a massive scale, but not well. Cannabis thrives with a gardener’s touch and loving attention, and the element of human connection is, in my experience, an integral part of the plant’s vitality.

If you could give one tip to beginners, what would it be? What about other professionals?

For beginners, I would suggest growing organic in the best soil you can make, and to avoid the use of fertilizer salts. Connect with and talk to your plants; grow with them and meditate on their health and vitality. Know that your plants are aware of your presence and resonate with them on a vibrational level.

For professionals, never cut corners, and stay connected with your plants even if it means longer work hours. Keep your fundamentals sound and keep experimenting while logging all of your data.

How has demand changed over the years?

The demand for new genetics is constant, and every year there are more and more people wanting to grow BC Bud Depot genetics in their gardens, for the joy of it more than for any other reason. People start growing, fall in love with the process and become interested in growing new and exotic cultivars. Seasoned and veteran growers find their elite strains and comfort levels. Legalization has accelerated this trend, and even more people are experiencing the joy of cultivating their own cannabis.

The award-winning BC God Bud in all of her glory.

Which BC Bud Depot strains are most popular?

BC God Bud still remains our most popular strain, 15 years after it was released for the world to enjoy. Other classics like Original Blueberry, The Purps, and Girl Scout Cookies are still very popular. The Tangie Cookies and Animal Cookies are growing in popularity. We expect that the soon to be released Wedding Cake will be a hit!

Which BC Bud Depot strains are your favorites?

Every strain in the catalog is a favorite. There are dozens upon dozens more that haven’t quite achieved favorite status, so they’re not in the catalog and stay in the vault, or are works in progress for now. We are always working on developing new elite strains.

How has cannabis legalization in Canada affected your business?

It’s created an environment in which we can make new partnerships out in the open, and have access to resources that were previously unavailable to us, such as genome sequencing. There are a lot of very bright people entering the industry now; that the stigma and legal liability are things of the past. It allows us to operate how we have always wanted to throughout those dark years of prohibition. It has been an overall positive transition, with many new opportunities and relationships among professionals and the general public, now that we can all work out in the open. Legalization has shone a bright spotlight upon us and the industry, which allows us to share the benefits of our unparalleled cannabis genetics with even more people.

Cannabis

Speakeasy Plans a November 5 Medical Cannabis Opening in Maysville

Published

on

Brick coffee shop exterior with a striped awning

Speakeasy Dispensary plans to open its Maysville medical cannabis store at 11 a.m. Eastern on Thursday, November 5, at 317 W. Second Street. The opening gives eligible patients in Mason County another place to plan a dispensary visit. For residents who are still applying for a Kentucky medical cannabis card, the company has also listed a patient drive at the same address.

The company announced the opening November 3. The Mason County Post previously reported that the storefront was coming to downtown Maysville near Caproni’s on the River. Patients traveling specifically for the launch should check with the store before leaving, especially if they need to arrange a ride or coordinate with a caregiver.

Two reasons to visit the same address

Speakeasy’s event calendar lists the Maysville patient drive from 11 a.m. to 5 p.m. on November 5. Those hours describe the event. Anyone planning to shop later in the week should check the store’s regular hours separately. If the purpose of the trip is to learn how to apply, check the event listing for registration details and ask the organizer what paperwork to bring.

The distinction matters because a patient drive and a dispensary purchase happen at different points in the process. Kentucky’s patient and caregiver FAQ directs prospective Kentucky patients to an authorized practitioner for written certification and to the state for the registry identification card application. A prospective patient can use the drive to ask about those steps. Someone who already has an active card can focus on store hours, what identification the retailer requests and whether the relevant product is available.

For households coordinating care, the state has a separate designated caregiver process. The patient must designate the caregiver through the registry application process, and the caregiver must also apply and receive approval. Kentucky says a designated caregiver may buy medical cannabis for the registered patients they have been approved to assist. That makes it useful to confirm whose registry credentials are current before deciding who will make the trip.

What a closer storefront changes

A local dispensary can make a recurring errand easier to coordinate. The practical gain is especially clear if a patient has to work around someone else’s availability or combine the visit with other stops. But the address alone tells readers little about the time a particular visit will take, the cost of a purchase or the menu on opening day. The announcement establishes the location and planned opening, so call the retailer for those other details before treating a trip as settled.

The distinction between a license and an operating storefront came up in our October coverage of Kentucky’s dispensary rollout. That statewide story used the state directory to distinguish retail locations patients could visit from businesses still working toward operation. Maysville gives readers a specific address and opening date to follow. A new statewide count would require checking the current directory, including changes elsewhere in the state since that earlier report.

Check the rules before crossing the river

Maysville’s location on the Ohio River adds another question for readers coming from outside Kentucky. The state describes a visiting qualified patient pathway with eligibility conditions, including a valid out-of-state registry card and documentation of a qualifying diagnosis. Check the Kentucky program’s current patient guidance and ask the store what documentation it needs before traveling. Permission to purchase in Kentucky and the rules that apply when traveling with cannabis are separate questions. A dispensary visit should not be treated as permission to take a purchase across a state line.

Check product rules as well as purchase eligibility. Kentucky lists forms such as oils, edibles and raw plant material among products its medical program allows, subject to program rules. The state prohibits smoking the raw plant material. Seeing flower on a menu therefore does not tell a patient how it may be used. For a first visit, the most useful questions are concrete: whether the store is open, whether the patient or caregiver has the required documents, and whether the intended product is available. For someone just getting started, the patient drive offers a separate opportunity to ask how to enter the program.

For patients comparing locations, Kentucky’s program resources are a useful place to start before checking an individual store. Keep the clinic visit, application and dispensary trip separate when planning time and transportation. A person attending the drive for information may have no reason to arrange a second trip until they know what the state requires and where they are in the application process.

Illustrative storefront photo of a coffee shop in Austin, Texas. Photo: Raphael Loquellano / Pexels.

Continue Reading

Cannabis

Cannabis Shoppers Expect Tax Savings to Reach the Shelf. Will They?

A NuggMD survey reported this week finds that 74 percent expect cannabis companies to pass on tax savings. The result measures consumer expectations, not an observed price cut.

Published

on

A hand using a pink calculator beside receipts and paperwork.

Cannabis consumers are looking for a share of the savings if federal tax relief improves operators’ finances. A NuggMD poll reported November 3 found that 74 percent of respondents expect companies to pass along savings through lower prices if rescheduling brings tax relief. The result captures a clear consumer expectation. It does not establish that prices have fallen or that every cannabis business receives the same relief.

Marijuana Moment’s Tom Angell reported the findings from 654 consumers in state-legal markets surveyed October 8–15. The reported margin of error was approximately 3.83 percentage points. Twenty-six percent expected companies to retain the savings while keeping prices at their current level.

What the survey can tell us

The question was conditional: it asked what consumers expected if companies received rescheduling-related tax relief. That wording is important. Respondents were not reporting a verified reduction in a particular operator’s tax bill, and they were not comparing receipts before and after a change in federal policy.

The sample also consisted of cannabis consumers in legal markets, rather than all American adults. Its findings should be described within that population. The publicly reported summary provides useful dates, sample size and question wording, but does not establish that every state, product category or type of consumer shares the same view.

For operators, the finding is a communication challenge as much as a pricing question. Customers may hear a headline about lower taxes and reasonably ask what it changes for them. A clear answer needs to separate the business’s actual eligibility, the timing of any benefit and the decisions it makes about retail prices.

Why Section 280E matters

Section 280E is the federal tax provision at the center of the discussion. In its April 23 announcement, Treasury and the IRS explained that the provision generally denies deductions and credits for businesses trafficking in Schedule I or II controlled substances in violation of federal or state law.

The agencies said the medical-marijuana rescheduling order generally removes that barrier for activities that, because of the order, no longer involve Schedule I or II substances. They also described planned guidance for businesses conducting multiple activities, including how expenses might be apportioned. That is a more qualified proposition than saying the tax restriction has disappeared for every cannabis sale.

Treasury’s statement anticipated a transition rule related to the taxable year containing the order’s effective date. The announcement describes expected guidance; it should not be treated as a substitute for checking the rules and advice applicable to a particular business. This article is about the consumer implications of the policy debate, rather than instructions for preparing a return.

Tax treatment is not a shelf-price rule

The IRS’s cannabis industry guidance continues to distinguish tax responsibilities from the legality of the underlying activity. Income remains reportable, and businesses must keep records and meet applicable payment and information-reporting requirements. Relief from a specific restriction does not remove the rest of the tax system.

There is also a basic distinction between lowering taxable income through a deduction and reducing a product’s price by the same dollar amount. A deduction affects how a business calculates its tax obligation. A retail price is what that business charges for a particular product. The two can be connected through business decisions without being mechanically identical.

The relevant question for a consumer is therefore more specific than whether a store sells cannabis. It is which activities qualify for the changed treatment, when that treatment applies and how the operator explains any resulting benefit.

That leaves several possibilities for any operator benefiting from relief: lower prices, investment in the business, improved financial resilience or some combination. The poll does not identify what companies will choose, and it would be premature to promise customers a uniform discount. Equally, an operator should not present a possible tax improvement as evidence that its shoppers have already benefited.

What consumers can actually compare

The clearest evidence for a customer is the price of a comparable purchase over time. Comparing the same product size and formulation, and distinguishing the base price from taxes or a temporary promotion, is more informative than treating a general rescheduling headline as a receipt.

Our coverage of medical cannabis registrations explains another part of the changing federal framework. Registration, tax treatment and retail pricing are related developments, but each requires its own evidence.

The survey’s immediate message is therefore straightforward: many cannabis shoppers expect a benefit they can see. Whether that expectation is met will be demonstrated by actual pricing and company disclosures, rather than by a poll result or a promised future guidance document alone.

Illustrative stock budgeting photograph; not a cannabis customer or company account. Photo: Kaboompics / Pexels.

Continue Reading

Cannabis

Houston’s Cannabis Enforcement Vote Now Turns to Implementation

Houston’s approved charter change focuses on police priorities, diversion and public accounting. It does not create a legal cannabis market or guarantee that possession cannot lead to enforcement.

Published

on

Houston voters have approved a charter amendment directing city police to give Class A and Class B misdemeanor marijuana possession their lowest enforcement priority. The cannabis provision sits alongside a ban on no-knock warrants in Proposition A, also called the Houston Freedom Act. The next part of the story is how the city translates those instructions into budgets, police policies, training and public reports.

Tom Angell’s election-night report for Marijuana Moment described the measure as approved, with an early count showing roughly 72 percent support. That was a preliminary result, rather than a certified final percentage. The policy’s meaning is best assessed against the charter language published by the city.

Lower priority has a defined scope

The text directs the Houston Police Department to make the specified misdemeanor possession offenses its lowest possible enforcement priority unless a binding state or federal court action requires otherwise. It calls for corresponding changes to the annual budget, department manual and relevant procedures. That links the policy to how the city allocates work and resources, not just to a statement of preference.

The charter language also preserves limits that matter to residents. An officer who has probable cause to believe a substance is marijuana may seize it and must explain the grounds in a report. The diversion section preserves law-enforcement and prosecutorial discretion to enforce state law. A lower-priority directive therefore should not be described as a guarantee against a police encounter, seizure or prosecution.

Nor does a city enforcement measure establish a state-licensed adult-use market. It does not create retail licenses or set up a new system for purchasing cannabis. Those are different legal questions from how municipal personnel prioritize a category of existing offenses. The practical distinction is essential for anyone reading the outcome as permission to possess or sell marijuana.

Diversion is part of the design

The measure supports diversion where legally permissible for people accused of the covered offenses. Examples in the text include mental-health or substance-use treatment referrals, community service and other alternatives to arrest or prosecution consistent with the cited Texas criminal-procedure provision.

That language describes a policy direction with legal qualifications. It does not promise that every individual will receive the same referral or qualify for the same alternative. Implementation will need to show what options are actually available and how decisions are made. An announcement that a measure passed cannot answer those case-specific questions.

The campaign organization Ground Game Texas promoted the Houston Freedom Act as an effort to redirect police resources and change marijuana enforcement. Its support explains the initiative’s advocacy context. The adopted language, subsequent city policies and actual enforcement records will be more useful for assessing results than campaign expectations alone.

The accounting provisions deserve attention

The city’s published text requires a one-time review of misdemeanor marijuana enforcement during the preceding five years. The audit is to include arrests, citations and demographic information, alongside estimates of staff hours, per-charge costs and spending on THC testing and enforcement. It is intended to be presented at a public council meeting and made available online.

The annual reporting requirement adds another way to follow implementation. The text calls for information including arrests, citations, diversion referrals, demographic breakdowns and estimated staff hours. This creates a framework for asking whether the new priority is reflected in practice. A report’s existence would not establish success on its own; the contents and their consistency over time will matter.

The THC-testing provisions similarly seek visibility into spending and staff time. That is a different question from whether testing can ever occur. The charter text contemplates council funding for testing when a compelling public-safety purpose is identified. Readers should avoid turning a budget-transparency provision into a claim that the city has prohibited every test.

What to watch after the vote

The no-knock provision is a separate substantive part of the same amendment. It bars Houston officers from requesting or executing warrants that do not require announcement and a wait of at least 15 seconds before entry. Its inclusion helps explain why Proposition A cannot be reduced to a cannabis-only retail or possession proposal.

For cannabis readers, the useful next milestones are official election certification, implementation instructions and the required public accounting. Those will show how the city applies a lower-priority policy while operating within the legal limits stated in the measure.

Our Idaho ballot coverage concerned who could change cannabis law. Houston’s vote concerns municipal enforcement priorities. Both involve voter participation, but their effects should be judged on the specific language voters approved rather than treated as interchangeable forms of legalization.

Illustrative stock view of Houston; not election-night photography. Photo: Eddie O. / Pexels.

Continue Reading

Trending

Join The Cannabis Aficionado Community!
Join the Cannabis Aficionado community and receive all of the most relevant news geared towards our sophisticated enthusiast community.
Loading

Copyright ©️ 2026 Cannabis Aficionado. Cannabis Aficionado is a registered trademark of CNM Inc. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service, Privacy Policy and Cookies Policy. People may receive compensation for some links to products and services. Offers may be subject to change without notice.